Education
About Us
Working with TipRanks
Follow Us
VMAX - ETF AI Analysis
Top Page
Hartford US Value ETF (VMAX)
Rating:72Outperform
Price Target:
$58.00
Positive Factors
Strong Year-to-Date Performance
The ETF has delivered solid year-to-date returns, indicating strong overall momentum.
Low Expense Ratio
With a competitive expense ratio of 0.29%, the fund offers cost-efficient exposure compared to many peers.
Sector Diversification
The ETF is spread across multiple sectors, including Financials, Health Care, and Technology, reducing reliance on any single industry.
Negative Factors
Over-Concentration in U.S. Market
With nearly 99% exposure to U.S. companies, the fund lacks geographic diversification and is vulnerable to domestic market risks.
Mixed Performance of Top Holdings
Some top holdings, such as UnitedHealth and EOG Resources, have underperformed year-to-date, potentially dragging on returns.
Heavy Financial Sector Exposure
Over 31% of the portfolio is allocated to Financials, making the fund sensitive to downturns in this sector.
VMAX vs. SPDR S&P 500 ETF (SPY)
AUM46.62M
RegionNorth America
Expense Ratio0.29%
Beta0.87
IssuerHartford
Inception DateDec 06, 2023
Dividend Yield1.87%
Asset ClassEquity
Index TrackedHartford US Value Index - Benchmark TR Gross
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume167
30 Day Avg. Volume514
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
60.63Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering138
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
VMAX Summary
The Hartford US Value ETF (Ticker: VMAX) is an investment fund that focuses on large U.S. companies considered undervalued, meaning their stock prices are low compared to their earnings or other financial metrics. It includes well-known companies like UnitedHealth and Meta Platforms, and it primarily invests in sectors like financials, healthcare, and technology. This ETF is a good choice for investors looking to diversify with stable, established companies that may offer steady growth and income through dividends. However, since it focuses on value stocks, its performance can be slower during periods when growth stocks dominate the market.
How much will it cost me?The Hartford US Value ETF (VMAX) has an expense ratio of 0.29%, meaning you’ll pay $2.90 per year for every $1,000 invested. This cost is slightly higher than average for passively managed ETFs because it focuses on a specific niche of large-cap value stocks, which may require more active research and management. Overall, it’s a reasonable fee for its targeted investment strategy.
What would affect this ETF?The Hartford US Value ETF (VMAX) could benefit from a stable U.S. economy and rising interest rates, which often support financial sector performance, its largest exposure. Additionally, strong demand for healthcare and technology innovations may drive growth in those sectors. However, economic slowdowns or regulatory changes in key industries like energy or financials could negatively impact the ETF's holdings, and shifts in consumer behavior might affect companies in communication services and consumer sectors.
VMAX Top 10 Holdings
The Hartford US Value ETF leans heavily into financials, with names like Citigroup and State Street driving steady performance thanks to strong earnings calls and reasonable valuations. Health care stocks, including CVS Health and Gilead Sciences, are rising on solid fundamentals and optimistic growth outlooks, adding resilience to the fund. However, energy exposure through EOG Resources is dragging the fund, as recent declines in revenue and cash flow weigh on its momentum. With a U.S.-centric portfolio and a focus on large-cap value, this ETF offers a stable yet sector-concentrated approach to long-term investing.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| NRG Energy | 2.34% | $1.08M | $31.95B | 75.74% | 67 Neutral | |
| CVS Health | 2.13% | $986.11K | $98.43B | 47.82% | 74 Outperform | |
| UnitedHealth | 2.07% | $956.10K | $291.30B | -46.73% | 76 Outperform | |
| Citigroup | 2.05% | $946.72K | $181.59B | 45.99% | 67 Neutral | |
| State Street | 2.04% | $942.22K | $33.43B | 25.46% | 74 Outperform | |
| Alphabet Class A | 2.03% | $938.54K | $3.50T | 60.40% | 80 Outperform | |
| Gilead Sciences | 1.93% | $891.18K | $146.59B | 29.90% | 77 Outperform | |
| Synchrony Financial | 1.71% | $792.35K | $26.90B | 14.28% | 72 Outperform | |
| Bank of New York Mellon | 1.70% | $788.09K | $77.38B | 42.72% | 79 Outperform | |
| EOG Resources | 1.67% | $772.55K | $57.82B | -17.87% | 74 Outperform |
VMAX Technical Analysis
Positive
―
Price Trends
53.01
Positive
51.85
Positive
49.69
Positive
Market Momentum
0.07
Negative
55.46
Neutral
71.75
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For VMAX, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 53.07, equal to the 50-day MA of 53.01, and equal to the 200-day MA of 49.69, indicating a bullish trend. The MACD of 0.07 indicates Negative momentum. The RSI at 55.46 is Neutral, neither overbought nor oversold. The STOCH value of 71.75 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for VMAX.
VMAX Peer Comparison
Comparison Results
Performance Comparison
VMAX
Hartford US Value ETF
53.49
3.33
6.64%
REVS
Columbia Research Enhanced Value ETF
―
―
―
SPVM
Invesco S&P 500 Value with Momentum ETF
―
―
―
MAVF
Matrix Advisors Value ETF
―
―
―
SPDV
AAM S&P 500 High Dividend Value ETF
―
―
―
BLCV
BlackRock Large Cap Value ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents